国际麻醉学与复苏杂志   2022, Issue (3): 0-0
    
不同剂量舒芬太尼术后镇痛方案对面肌痉挛微血管减压术后恶心呕吐的影响
高鑫, 李京生, 封光, 刘扬, 王天龙1()
1.首都医科大学宣武医院
Effects of different doses of sufentanil postoperative analgesia on nausea and vomiting after microvascular decompression for hemifacial spasm
 全文:
摘要:

目的 观察面肌痉挛微血管减压术后应用不同剂量舒芬太尼镇痛方案对术后恶心呕吐不良反应的影响。 方法 回顾性纳入行微血管减压术的面肌痉挛女性患者183例,在相同麻醉方法的基础上根据术后是否使用舒芬太尼镇痛泵及其不同剂量将患者分为舒芬太尼2 μg/kg组(A组,60例)、舒芬太尼1 μg/kg组(B组,60例)和未使用镇痛泵组(C组,63例)。主要观察指标为3组患者术后2、8、24 h恶心呕吐的发生率。次要观察指标为3组患者手术时间,麻醉时间,术后2、8、24 h的VAS疼痛评分等级。 结果 A组患者术后2、8、24 h恶心呕吐发生率高于B组(2 h χ2=5.67,P=0.017;8 h χ2=8.57,P=0.003;24 h χ2=6.72,P=0.010)。A组患者术后2、8、24 h恶心呕吐发生率高于C组(2 h χ2=4.47,P=0.034;8 h χ2=4.55,P=0.033;24 h χ2=5.01,P=0.025)。B组与C组患者各时点恶心呕吐发生率差异无统计学意义(2 h χ2=0.09,P=0.764;8 h χ2=0.72,P=0.395;24 h χ2=0.16,P=0.691)。术后2 h,三组患者VAS疼痛评分无痛差异无统计学意义(P>0.01),C组轻至重度疼痛评分等级高于A组(Z=7.12,P<0.001)及B组(Z=6.06,P<0.001),A组与B组比较差异无统计学意义(Z=1.73,P=0.085)。术后8 h,C组与B组比较VAS疼痛评分无痛差异无统计学意义(P>0.01),轻至重度疼痛评分等级高于B组(Z=5.50,P<0.001),C组疼痛评分等级高于A组(Z=6.45,P<0.001),A组与B组比较差异无统计学意义(Z=1.69,P=0.091)。术后24 h,C组VAS疼痛评分等级高于A组(Z=5.62,P<0.001)及B组(Z=5.30,P<0.001),A组与B组比较差异无统计学意义(Z=0.06,P=0.948)。3组患者手术时间、麻醉时间差异无统计学意义(P>0.05)。 结论 面肌痉挛微血管减压术后,应用舒芬太尼1 μg/kg术后镇痛泵方案可有效降低术后VAS疼痛评分等级,且不增加术后恶心呕吐的发生率。

关键词: 面肌痉挛; 微血管减压术; 舒芬太尼; 术后镇痛; 恶心呕吐
Abstract:

Objective To observe the effect of different doses of sufentanil analgesia on postoperative nausea and vomiting after microvascular decompression for hemifacial spasm. Methods A total of 183 female patients with hemifacial spasms who underwent microvascular decompression were retrospectively enrolled. Based on the same anesthesia method, according to the use of different doses of sufentanil in postoperative analgesic pump, they were divided into three groups: a sufentanil 2 μg/kg group (group A, n=60), a sufentanil 1 μg/kg group (group B, n=60) and a non-analgesic pump group (group C, n=63). The primary outcomes were the incidence of nausea and vomiting 2, 8 h and 24 h after operation in the three groups. The secondary outcomes were the operation time, the anesthesia time, and the Visual Analog Scale (VAS) score 2, 8 h and 24 h after operation. Results The incidence of nausea and vomiting in group A was higher than that in group B 2, 8 h, and 24 h after operation (2 h χ2=5.67, P=0.017; 8 h χ2=8.57, P=0.003; 24 h χ2=6.72, P=0.010). The incidence of nausea and vomiting in group A was higher than that in group C 2, 8 h and 24 h after operation (2 h χ2=4.47, P=0.034; 8 h χ2=4.55, P=0.033; 24 h χ2=5.01, P=0.025). There was no significant difference in the incidence of nausea and vomiting between group B and group C at each time point (2 h χ2=0.09, P=0.764; 8 h χ2=0.72, P=0.395; 24 h χ2=0.16, P=0.691). Then, 2 h after operation, there was no significant difference in the painless grade of VAS scores among the three groups (P>0.01); the grade of mild to severe pain in group C was higher than that in group A (Z=7.12, P<0.001) and group B (Z=6.06, P<0.001); and there was no significant difference be tween group A and group B (Z=1.73, P=0.085). Furthermore, 8 h after operation, there was no significant difference in the painless grade of VAS scores between group C and group B (P>0.01), and the grade of mild to severe pain in group C was higher than that in group B (Z=5.50, P<0.001); the grade of pain in group C was higher than that in group A (Z=6.45, P<0.001); and there was no significant difference between group A and group B (Z=1.69, P=0.091). Then, 24 h after operation, the VAS score in group C was higher than that in group A (Z=5.62, P<0.001) and group B (Z=5.30, P<0.001); and there was no significant difference between group A and group B (Z=0.06, P=0.948). There was no significant difference in operation time and anesthesia time among the three groups (P>0.05). Conclusions After microvascular decompression for hemifacial spasms, the application of 1 μg/kg sufentanil postoperative analgesia can effectively reduce the postoperative VAS score without increasing the incidence of postoperative nausea and vomiting.

Key words: Hemifacial spasm; Microvascular decompression; Sufentanil; Postoperative analgesia; Nausea and vomiting